Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

61.

Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch.

Cell.
Cohen P, Levy JD, Zhang Y, Frontini A, Kolodin DP, Svensson KJ, Lo JC, Zeng X, Ye L, Khandekar MJ, Wu J, Gunawardana SC, Banks AS, Camporez JP, Jurczak MJ, Kajimura S, Piston DW, Mathis D, Cinti S, Shulman GI, Seale P, Spiegelman BM.
| Jan 16, 2014
62.

What we talk about when we talk about fat.

Cell.
Rosen ED, Spiegelman BM.
| Jan 16, 2014
63.

Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.

Nat. Genet.
Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, Lawrence MS, Rodriguez FJ, Bernardo LA, Schubert L, Sunkavalli A, Shillingford N, Calicchio ML, Lidov HG, Taha H, Martinez-Lage M, Santi M, Storm PB, Lee JY, Palmer JN, Adappa ND, Scott RM, Dunn IF, Laws ER, Stewart C, Ligon KL, Hoang MP, Van Hummelen P, Hahn WC, Louis DN, Resnick AC, Kieran MW, Getz G, Santagata S.
| 01 12, 2014
64.

Broadly permissive intestinal chromatin underlies lateral inhibition and cell plasticity.

Nature.
Kim TH, Li F, Ferreiro-Neira I, Ho LL, Luyten A, Nalapareddy K, Long H, Verzi M, Shivdasani RA.
| Feb 27, 2014
65.

Analysis of chromatin-state plasticity identifies cell-type-specific regulators of H3K27me3 patterns.

Proc. Natl. Acad. Sci. U.S.A.
Pinello L, Xu J, Orkin SH, Yuan GC.
| Jan 21, 2014
66.

Discovery and saturation analysis of cancer genes across 21 tumour types.

Nature.
Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, Meyerson M, Gabriel SB, Lander ES, Getz G.
| Jan 23, 2014
67.

Landscape of genomic alterations in cervical carcinomas.

Nature.
Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio L, Cibulskis K, Bertelsen B, Romero-Cordoba S, Treviño V, Vazquez-Santillan K, Guadarrama AS, Wright AA, Rosenberg MW, Duke F, Kaplan B, Wang R, Nickerson E, Walline HM, Lawrence MS, Stewart C, Carter SL, McKenna A, Rodriguez-Sanchez IP, Espinosa-Castilla M, Woie K, Bjorge L, Wik E, Halle MK, Hoivik EA, Krakstad C, Gabiño NB, Gómez-Macías GS, Valdez-Chapa LD, Garza-Rodríguez ML, Maytorena G, Vazquez J, Rodea C, Cravioto A, Cortes ML, Greulich H, Crum CP, Neuberg DS, Hidalgo-Miranda A, Escareno CR, Akslen LA, Carey TE, Vintermyr OK, Gabriel SB, Barrera-Saldaña HA, Melendez-Zajgla J, Getz G, Salvesen HB, Meyerson M.
| Feb 20, 2014
68.

Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging.

Cell.
Gomes AP, Price NL, Ling AJ, Moslehi JJ, Montgomery MK, Rajman L, White JP, Teodoro JS, Wrann CD, Hubbard BP, Mercken EM, Palmeira CM, de Cabo R, Rolo AP, Turner N, Bell EL, Sinclair DA.
| Dec 19, 2013
69.

Dynamic control of β1 integrin adhesion by the plexinD1-sema3E axis.

Proc. Natl. Acad. Sci. U.S.A.
Choi YI, Duke-Cohan JS, Chen W, Liu B, Rossy J, Tabarin T, Ju L, Gui J, Gaus K, Zhu C, Reinherz EL.
| Jan 7, 2014
70.

Genetic disruption of CD8+ Treg activity enhances the immune response to viral infection.

Proc. Natl. Acad. Sci. U.S.A.
Holderried TA, Lang PA, Kim HJ, Cantor H.
| Dec 24, 2013
71.

The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins.

Science.
Lu G, Middleton RE, Sun H, Naniong M, Ott CJ, Mitsiades CS, Wong KK, Bradner JE, Kaelin WG.
| Jan 17, 2014
72.

Inconsistency in large pharmacogenomic studies.

Nature.
Haibe-Kains B, El-Hachem N, Birkbak NJ, Jin AC, Beck AH, Aerts HJ, Quackenbush J.
| Dec 19, 2013
73.

A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species.

Cell.
Xu C, Tabebordbar M, Iovino S, Ciarlo C, Liu J, Castiglioni A, Price E, Liu M, Barton ER, Kahn CR, Wagers AJ, Zon LI.
| Nov 7, 2013
74.

Lin28 enhances tissue repair by reprogramming cellular metabolism.

Cell.
Shyh-Chang N, Zhu H, Yvanka de Soysa T, Shinoda G, Seligson MT, Tsanov KM, Nguyen L, Asara JM, Cantley LC, Daley GQ.
| Nov 7, 2013
75.

The quest to overcome resistance to EGFR-targeted therapies in cancer.

Nat. Med.
Chong CR, Jänne PA.
| 11 07, 2013
76.

Development. A stem cell perspective on cellular engineering.

Science.
Doulatov S, Daley GQ.
| Nov 8, 2013
77.

Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.

Nat. Genet.
Francis JM, Kiezun A, Ramos AH, Serra S, Pedamallu CS, Qian ZR, Banck MS, Kanwar R, Kulkarni AA, Karpathakis A, Manzo V, Contractor T, Philips J, Nickerson E, Pho N, Hooshmand SM, Brais LK, Lawrence MS, Pugh T, McKenna A, Sivachenko A, Cibulskis K, Carter SL, Ojesina AI, Freeman S, Jones RT, Voet D, Saksena G, Auclair D, Onofrio R, Shefler E, Sougnez C, Grimsby J, Green L, Lennon N, Meyer T, Caplin M, Chung DC, Beutler AS, Ogino S, Thirlwell C, Shivdasani R, Asa SL, Harris CR, Getz G, Kulke M, Meyerson M.
| 11 03, 2013
78.

A melanocyte lineage program confers resistance to MAP kinase pathway inhibition.

Nature.
Johannessen CM, Johnson LA, Piccioni F, Townes A, Frederick DT, Donahue MK, Narayan R, Flaherty KT, Wargo JA, Root DE, Garraway LA.
| Dec 5, 2013
79.

Cancer-drug discovery and cardiovascular surveillance.

N. Engl. J. Med.
Groarke JD, Cheng S, Moslehi J.
| Nov 7, 2013
80.

Linking the SWI/SNF complex to prostate cancer.

Nat. Genet.
Lee RS, Roberts CW.
| 10 30, 2013